Description

Graniz (Granisetron Hydrochloride Injection 3 mg) is a prescription medicine containing Granisetron Hydrochloride, a 5-HT3 (serotonin) receptor antagonist used to help prevent and treat nausea and vomiting associated with chemotherapy, radiotherapy, and surgery. It works by blocking serotonin receptors that trigger nausea and vomiting, providing effective symptom control during cancer treatment and the perioperative period. Graniz is administered by qualified healthcare professionals through intravenous (IV) injection or infusion. The dosage and timing are determined by the treating physician based on the patient's age, medical condition, and treatment regimen. Key Benefits Contains Granisetron Hydrochloride 3 mg, a proven antiemetic. Helps prevent chemotherapy-induced nausea and vomiting (CINV). Effective in reducing radiotherapy-induced nausea and vomiting (RINV). May be used to prevent and treat postoperative nausea and vomiting (PONV). Sterile injectable formulation for hospital and clinical use. Manufactured according to high pharmaceutical quality standards. Indications Graniz (Granisetron Hydrochloride Injection 3 mg) may be prescribed for: Prevention of chemotherapy-induced nausea and vomiting (CINV). Prevention and treatment of radiotherapy-induced nausea and vomiting (RINV). Prevention and treatment of postoperative nausea and vomiting (PONV). Administration For intravenous (IV) administration by trained healthcare professionals. Dosage is individualized based on the patient's clinical condition and treatment protocol. Follow the prescribing physician's instructions regarding administration and monitoring.